Mrunali Patel
Charotar University of Science and Technology Ramanbhai Patel College of Pharmacy, Indukaka Ipcowala College of Pharmacy
0000-0002-8313-6266
About
Mrunali Patel, Ph.D., is a distinguished Pharmaceutical Technology Expert and researcher specializing in advanced drug delivery systems and translational pharmaceutical sciences. Her extensive research portfolio focuses on the design, characterization, and evaluation of novel therapeutic platforms, including nanoemulsion and microemulsion platforms, lipid–polymer nanocarriers, and hybrid lipid–polymer therapeutic systems.
Dr. Patel has pioneered significant advancements in targeted and specialized drug delivery, with a particular emphasis on intranasal and brain-targeted delivery, as well as pulmonary drug delivery systems designed for lung cancer therapeutics. Methodologically, she integrates modern Analytical Quality by Design (AQbD) principles into rigorous analytical method development and validation.
An accomplished author and academic collaborator, Dr. Patel is the co-editor of the definitive text Nanotechnology in Medicine: Toxicity and Safety (Wiley, 2021). Her research is widely published in high-impact, peer-reviewed journals, including: International Journal of Biological Macromolecules, AAPS PharmSciTech, Journal of Drug Delivery Science and Technology, International Journal of Pharmaceutics, European Polymer Journal, etc.
In addition to her journal publications, she has contributed numerous book chapters and foundational research pieces to the global pharmaceutical science community.
Employment
-
Charotar University of Science and Technology Ramanbhai Patel College of Pharmacy Professor2020 - Present
-
Charotar University of Science and Technology Ramanbhai Patel College of Pharmacy Associate Professor2017 - 2020
-
Indukaka Ipcowala College of Pharmacy Assistant Professor2005 - 2016
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (106)
- Nose-to-Brain Targeted Mucoadhesive Nanoemulsion for Management of Schizophrenia: Development and Pharmacodynamic Evaluation Save
- AQbD-based stability-indicating RP-HPLC method as common analytical platform for quantification of ezetimibe in combination with atorvastatin or pitavastatin across marketed tablet formulations Save
- Compatibility and physicochemical stability of ceftriaxone for injection admixed with pantoprazole sodium and ondansetron hydrochloride in different infusion solutions Save
- Emerging Role of Carbon Nanodots in Cancer Therapy Save
- Quantifying alpha arbutin and niacinamide from nanocosmeceutical formulation matrix: AQbD driven high-performance thin-layer chromatographic method Save
- Apolipoprotein E3 functionalized mesoporous silica nanoparticles for targeted and enhanced therapeutic efficacy of Levetiracetam in brain tumor-associated epilepsy: Insights into brain uptake, biodistribution and pharmacokinetic behavior Save
- Harnessing Cu- and Fe-based metal-organic frameworks as innovative nanocarriers for enhanced fluconazole delivery in topical management of Candida albicans Save
- Unlocking the potential of novel hybrid lipid polymer nanoparticles in redefining camptothecin delivery: Achieving controlled release, enhanced cytotoxicity, and improved pharmacokinetics for colorectal cancer therapy Save
- AQbD integrated high-performance thin layer chromatographic method for quantitative estimation of Tavaborole in the presence of its degradants and the matrix of nanostructured lipid carriers Save
- Analytical Quality by Design Based HPLC for Quantitative Analysis of Teneligliptin and Rosuvastatin Calcium Tablets in the Presence of Force Degradation Products Save